100+ Free Eidgenössisches Examen Humanmedizin Practice Questions

Prepare for the Eidgenössische Prüfung in Humanmedizin / Examen fédéral en médecine humaine exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Swiss Federal Licensing Examination for Medical Professions (Eidgenössische Medizinalprüfungen)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

2026 Statistics

Key Facts: Eidgenössisches Examen Humanmedizin Exam

240 MCQs + 11 OSCEs

Exam Structure

BAG / MEBEK Regulations 2026

CHF 2,200

Total Federal Fees

Prüfungsverordnung MedBG

390 min

Written Exam Time

2 x 195 min CK Sessions

German / French

Official Languages

Swiss Confederation (BAG)

PROFILES

Curriculum Framework

SMIFK / Swiss Medical Faculties

100

Practice Questions

OpenExamPrep

The Eidgenössisches Examen Humanmedizin is the national licensing exam administered by BAG and MEBEKO for all Swiss medical graduates, consisting of 240 written MCQs (CK) and an 11-station OSCE (CS) based on the Swiss PROFILES learning catalog.

Sample Eidgenössisches Examen Humanmedizin Practice Questions

Try these sample questions to test your Eidgenössisches Examen Humanmedizin exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old male presents to the emergency department with acute, crushing substernal chest pain radiating to his left arm and jaw that started 45 minutes ago. He is diaphoresis and dyspneic. His 12-lead ECG demonstrates 3 mm ST-segment elevations in leads V1–V4 with reciprocal ST depressions in leads II, III, and aVF. Blood pressure is 135/85 mmHg, heart rate is 88 bpm, and SpO2 is 97% on room air. According to European Society of Cardiology (ESC) guidelines, what is the most appropriate immediate reperfusion and pharmacological strategy?

A.Immediate transfer for primary percutaneous coronary intervention (PCI) with target wire-crossing <90 minutes, loading with aspirin, a potent P2Y12 inhibitor (ticagrelor or prasugrel), and unfractionated heparin

B.Immediate IV fibrinolysis with tenecteplase in the emergency department followed by routine elective coronary angiography within 48 to 72 hours

C.Immediate administration of high-dose intravenous nitroglycerin, beta-blocker, and fondaparinux, delaying catheterization until high-sensitivity troponin levels peak

D.Immediate transfer for emergent coronary artery bypass grafting (CABG) as first-line revascularization for all anterior ST-segment elevation myocardial infarctions

Explanation: This patient has an acute anterior ST-segment elevation myocardial infarction (STEMI). According to ESC and Swiss cardiology guidelines, primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy when performed within 90 minutes of STEMI diagnosis. Immediate dual antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor (ticagrelor 180 mg or prasugrel 60 mg) plus unfractionated heparin is indicated.

2A 64-year-old female with ischemic cardiomyopathy presents for outpatient follow-up. Transthoracic echocardiography reveals a left ventricular ejection fraction (LVEF) of 28% with global hypokinesia. She reports dyspnea when walking up one flight of stairs (NYHA Class II). Her current medications are bisoprolol 5 mg daily and ramipril 5 mg daily. Blood pressure is 122/74 mmHg, heart rate is 68 bpm, eGFR is 62 mL/min/1.73m², and serum potassium is 4.3 mmol/L. According to ESC Heart Failure guidelines, which medical regimen constitutes optimal quadruple guideline-directed medical therapy (GDMT)?

A.Continue bisoprolol and ramipril, and add digoxin and ivabradine

B.Switch ramipril to an ARNI (sacubitril/valsartan), maintain bisoprolol, add a mineralocorticoid receptor antagonist (spironolactone or eplerenone), and add an SGLT2 inhibitor (dapagliflozin or empagliflozin)

C.Discontinue bisoprolol, increase ramipril to maximum tolerated dose, and initiate hydralazine plus isosorbide dinitrate monotherapy

D.Add amiodarone and furosemide while maintaining current doses of bisoprolol and ramipril without further neurohormonal blockade

Explanation: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF, LVEF ≤40%) consists of the 'four pillars': an ARNI (sacubitril/valsartan, or ACEi/ARB if ARNI is not tolerated), an evidence-based beta-blocker (bisoprolol, carvedilol, or metoprolol succinate), a mineralocorticoid receptor antagonist (MRA, eplerenone or spironolactone), and an SGLT2 inhibitor (dapagliflozin or empagliflozin). This combination provides additive mortality reduction.

3A 71-year-old male with a history of hypertension and type 2 diabetes mellitus presents with palpitations. An ECG confirms newly diagnosed atrial fibrillation with a ventricular response of 115 bpm. He has no prior history of stroke, TIA, or vascular disease. Echocardiography shows preserved left ventricular systolic function and no significant valvular disease. Blood pressure is 138/82 mmHg. What is his CHA2DS2-VASc score, and what is the recommended long-term antithrombotic management?

A.CHA2DS2-VASc = 1; prescribe low-dose aspirin 100 mg daily

B.CHA2DS2-VASc = 2; dual antiplatelet therapy with aspirin and clopidogrel for 12 months

C.CHA2DS2-VASc = 3; oral anticoagulation with a direct oral anticoagulant (DOAC, e.g., apixaban, edoxaban, or rivaroxaban) as preferred first-line therapy

D.CHA2DS2-VASc = 4; therapeutic intravenous unfractionated heparin bridging followed by lifelong vitamin K antagonist (warfarin/phenprocoumon) with target INR 3.0–4.0

Explanation: The CHA2DS2-VASc score assigns 1 point for Hypertension, 1 point for Diabetes mellitus, and 1 point for Age 65–74 years, totaling 3 points. In men with a CHA2DS2-VASc score ≥2 (and women ≥3), oral anticoagulation is strongly recommended (Class I) to prevent thromboembolic stroke. Direct oral anticoagulants (DOACs) are preferred over vitamin K antagonists due to lower intracranial hemorrhage rates and similar or superior efficacy.

4A 52-year-old male presents with a 4-week history of low-grade fever, night sweats, fatigue, and weight loss. On examination, a new 3/6 holosystolic murmur is heard loudest at the cardiac apex. Fundoscopic exam reveals retinal flame hemorrhages with pale centers (Roth spots), and splinter hemorrhages are visible under the fingernails. What is the most crucial initial diagnostic step before initiating antimicrobial therapy?

A.Immediate administration of empiric IV vancomycin plus gentamicin followed by a single set of blood cultures 6 hours later

B.Transesophageal echocardiography followed by therapeutic pericardiocentesis

C.Urgent cardiac MRI and serum troponin T measurement

D.Drawing at least three separate sets of blood cultures from different venipuncture sites spaced at least 30 to 60 minutes apart, followed by prompt transthoracic echocardiography (TTE)

Explanation: In suspected infective endocarditis (IE), drawing at least 3 sets of blood cultures from separate venipuncture sites before starting antibiotics is essential to maximize microbiological yield, identify the causative pathogen (e.g., viridans group streptococci, Staphylococcus aureus, Enterococcus faecalis), and guide definitive susceptibility-based antimicrobial therapy. Echocardiography (TTE initially, followed by TEE if needed) is the imaging modality of choice under Modified Duke Criteria.

5A 78-year-old woman presents with progressive exertional dyspnea and two recent episodes of presyncope while walking uphill. Cardiac auscultation reveals a harsh, crescendo-decrescendo systolic ejection murmur at the right upper sternal border radiating to the carotids, accompanied by a delayed and diminished carotid pulse (pulsus parvus et tardus) and a single soft second heart sound (S2). Transthoracic echocardiography shows a calcified trileaflet aortic valve with a peak transvalvular jet velocity of 4.4 m/s, mean pressure gradient of 48 mmHg, and an aortic valve area (AVA) of 0.7 cm². What is the definitive management of choice?

A.Aortic valve replacement (transcatheter aortic valve implantation [TAVI] or surgical aortic valve replacement [SAVR]) after Heart Team evaluation

B.Long-term medical therapy with high-dose loop diuretics and ACE inhibitors without procedural intervention

C.Percutaneous balloon aortic valvuloplasty as definitive lifelong corrective therapy

D.Prescription of beta-blockers and reassurance with repeat echocardiography in 12 months

Explanation: The patient has severe symptomatic aortic stenosis, defined by peak velocity ≥4.0 m/s, mean gradient ≥40 mmHg, AVA <1.0 cm², and classic symptoms (dyspnea, presyncope). Once symptoms develop, 2-year mortality exceeds 50% without intervention. Definitive management is aortic valve replacement (TAVI or SAVR based on Heart Team risk assessment, age, and anatomical suitability). Medical therapy does not prolong survival.

6A 29-year-old previously healthy male presents with sharp retrosternal chest pain that worsens with deep inspiration and when lying supine, and improves significantly when sitting forward. On physical exam, a pericardial friction rub is heard over the left lower sternal border. The 12-lead ECG demonstrates widespread concave ST-segment elevation across leads I, II, aVF, and V2–V6, along with PR-segment depression in lead II and PR elevation in lead aVR. Serum troponin is normal. What is the recommended first-line pharmacological treatment for acute viral/idiopathic pericarditis?

A.Oral high-dose prednisolone (1 mg/kg/day) as monotherapy for 4 weeks

B.A high-dose non-steroidal anti-inflammatory drug (NSAID, e.g., ibuprofen 600 mg TID or aspirin) combined with colchicine (0.5 mg QD/BID) for 3 months

C.Intravenous unfractionated heparin followed by therapeutic warfarin for 6 months

D.Emergency needle pericardiocentesis followed by broad-spectrum empiric IV vancomycin

Explanation: First-line therapy for acute pericarditis consists of high-dose NSAIDs (e.g., ibuprofen 600 mg TID or aspirin 750–1000 mg TID) tapered over 2–4 weeks, combined with weight-adjusted colchicine (0.5 mg once or twice daily) for 3 months to accelerate symptom resolution and significantly reduce recurrence rates. Systemic corticosteroids are reserved as second-line therapy when NSAIDs/colchicine are contraindicated or ineffective.

7A 68-year-old male with known severe COPD (GOLD 3, Group E) presents with a 3-day history of increased shortness of breath, increased sputum volume, and distinctly purulent (greenish) sputum production (Anthonisen Type 1 exacerbation). Vital signs: RR 26/min, SpO2 88% on room air, temperature 37.9°C. Chest radiography excludes pneumothorax and focal consolidation. Arterial blood gas on room air shows pH 7.36, PaCO2 48 mmHg, PaO2 56 mmHg, HCO3- 27 mmol/L. According to GOLD guidelines, what constitutes the most appropriate initial management?

A.Invasive endotracheal intubation, continuous theophylline infusion, and high-flow 100% oxygen via non-rebreather mask

B.Inhaled long-acting muscarinic antagonist (LAMA) monotherapy and immediate discharge home with oral acetaminophen

C.Controlled low-flow oxygen therapy (target SpO2 88–92%), inhaled short-acting bronchodilators (SABA/SAMA), oral systemic corticosteroid (prednisone 40 mg daily for 5 days), and oral antibiotic therapy (e.g., amoxicillin/clavulanate)

D.Intravenous methylprednisolone 500 mg daily for 14 days, prophylactic low-dose aspirin, and restriction of all inhaled bronchodilators

Explanation: For an acute COPD exacerbation with all three Anthonisen criteria (increased dyspnea, sputum volume, and sputum purulence), management includes: 1) controlled oxygen to target SpO2 88–92% to prevent hypercapnic respiratory drive suppression; 2) inhaled short-acting beta2-agonist + anticholinergic (SABA/SAMA); 3) oral prednisone (40 mg daily for 5 days); and 4) antibiotic therapy targeting Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis (e.g., amoxicillin/clavulanate).

8A 74-year-old woman presents to her general practitioner in Bern with a 3-day history of productive cough with rust-colored sputum, right pleuritic chest pain, and fever. On examination: fully alert and oriented (Confusion score = 0); Blood urea nitrogen is normal (Urea score = 0); Respiratory rate is 32/min (RR score = 1); Blood pressure is 105/65 mmHg (BP score = 0); Age is 74 (Age score = 1). Crackles and bronchial breath sounds are auscultated over the right lower lung zone. Chest X-ray confirms right lower lobe consolidation. What is her CURB-65 score and the guideline-recommended level of care?

A.CURB-65 score = 0; safe for outpatient home management with oral amoxicillin

B.CURB-65 score = 4; requires immediate admission to the intensive care unit (ICU) for invasive mechanical ventilation

C.CURB-65 score = 1; outpatient management with oral azithromycin monotherapy

D.CURB-65 score = 2; indicates intermediate mortality risk warranting hospital admission (general medical ward) and parenteral/oral antimicrobial therapy

Explanation: The CURB-65 score assesses: Confusion (0), Urea >7 mmol/L (0), Respiratory rate ≥30/min (1), Blood pressure <90 systolic or ≤60 diastolic (0), and Age ≥65 years (1), yielding a score of 2. A CURB-65 score of 2 represents intermediate risk (30-day mortality ~9%) and warrants hospital admission to a general medical ward for close monitoring and antimicrobial treatment (e.g., amoxicillin/clavulanate ± macrolide).

9A 26-year-old woman presents with episodic daytime wheezing and dry cough occurring 3 to 4 days per week, and nighttime awakenings due to shortness of breath twice a month. Spirometry reveals an FEV1 of 82% predicted that increases by 14% and 240 mL following inhalation of 400 mcg salbutamol. According to the Global Initiative for Asthma (GINA) Track 1 recommendations, what is the preferred first-line treatment strategy?

A.As-needed low-dose inhaled corticosteroid (ICS) combined with formoterol as the single maintenance and reliever therapy (SMART/MART)

B.Short-acting beta2-agonist (SABA, e.g., salbutamol) exclusively on an as-needed basis without any inhaled corticosteroid

C.Oral leukotriene receptor antagonist (montelukast) monotherapy without any inhaled inhaler

D.High-dose oral prednisone daily combined with regular long-acting theophylline tablets

Explanation: According to GINA guidelines (Track 1 preferred pathway), treatment with SABA alone is no longer recommended due to increased risk of severe exacerbations and asthma-related death. The preferred approach across all severity steps is an inhaled corticosteroid (ICS)-formoterol combination taken as needed for symptom relief (and as regular daily maintenance if in Steps 3–5). Formoterol provides rapid bronchodilation while the ICS suppresses underlying eosinophilic airway inflammation.

10A 54-year-old male who underwent total knee arthroplasty 10 days ago presents with sudden-onset pleuritic chest pain and dyspnea. Vital signs: BP 128/78 mmHg, HR 108 bpm, RR 22/min, SpO2 93% on ambient air. Physical exam shows a swollen, tender right calf. His modified Wells score is calculated as high risk (>6 points). What is the definitive first-line diagnostic imaging modality to confirm the suspected diagnosis, and what is the standard initial anticoagulation in hemodynamically stable patients?

A.D-dimer assay; if positive, perform ventilation-perfusion (V/Q) scan and start aspirin

B.Computed tomography pulmonary angiography (CTPA); start a direct oral anticoagulant (DOAC, e.g., apixaban, rivaroxaban) or low-molecular-weight heparin (LMWH)

C.Transthoracic echocardiogram; start immediate systemic intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA)

D.Chest radiography; perform urgent surgical pulmonary embolectomy without anticoagulation

Explanation: In patients with a high clinical pre-test probability of pulmonary embolism (Wells score >6), D-dimer testing should be bypassed, and computed tomography pulmonary angiography (CTPA) is the diagnostic imaging test of choice. In hemodynamically stable patients (non-high risk PE), therapeutic anticoagulation with a DOAC (e.g., apixaban or rivaroxaban without heparin lead-in, or dabigatran/edoxaban after 5 days of LMWH) is the preferred treatment.

About the Eidgenössisches Examen Humanmedizin Exam

The Eidgenössische Prüfung Humanmedizin (Federal Examination in Human Medicine / Examen fédéral en médecine humaine) is the mandatory national licensing examination required to obtain the Swiss Federal Medical Diploma (Eidgenössisches Diplom als Ärztin/Arzt) under the Federal Act on Medical Professions (Medizinalberufegesetz MedBG / LPMéd). Administered nationally under the authority of the Federal Office of Public Health (BAG) and the Medical Professions Commission (MEBEKO), the examination evaluates candidates against the Swiss PROFILES (Principal Objectives for Postgraduate Medical Training in Switzerland) learning catalog. It covers internal medicine, general and visceral surgery, traumatology, pediatrics, obstetrics and gynecology, psychiatry, emergency medicine, primary care, clinical pharmacology, and Swiss medical law and ethics (including KVG/LAMal, MedBG, ZGB, and SAMW directives). Note on format and language: While the official Swiss federal examination is administered in national languages (German and French) and comprises 240 written MCQs plus an 11-station practical OSCE, this question bank is an English-language multiple-choice study adaptation created by OpenExamPrep—not an official BAG/MEBEKO examination release—designed to help Swiss medical graduates and international medical doctors master high-yield clinical reasoning, diagnostic workflows, and guideline-adherent management.

Assessment

Two independent national examination components: 1) Clinical Knowledge (CK) written computer-based exam consisting of 240 single-best-answer MCQs (administered in two 195-minute sessions over two half-days), and 2) Clinical Skills (CS) practical examination consisting of 11 standardized OSCE stations (13 minutes per station with standardized patients, physical exam, procedural tasks, and communication). Both components are governed by MEBEKO and must be passed independently according to MedBG regulations (no compensation is permitted).

Time Limit

390 minutes written examination (two 195-minute sessions) plus approximately 3.5 hours for the 11 practical OSCE stations

Passing Score

Criterion-referenced standard passing score established annually by MEBEKO for the written CK examination, and a minimum station pass threshold for the practical CS OSCE examination

Exam Fee

CHF 200 registration fee + CHF 1,500 examination fee + CHF 500 federal diploma issuance fee (Total: CHF 2,200) (Bundesamt für Gesundheit (BAG / OFSP) and Medizinalberufekommission (MEBEKO Ressort Ausbildung))

Eidgenössisches Examen Humanmedizin Exam Content Outline

25%

General Internal Medicine & Subspecialties

Cardiology (coronary syndromes, heart failure, valvular disorders, arrhythmias), pneumology (COPD, asthma, pulmonary embolism, pneumonia, interstitial lung disease), gastroenterology and hepatology (pancreatitis, liver cirrhosis, IBD, GI hemorrhage), nephrology and fluid/electrolytes (AKI, CKD, hyponatremia, hyperkalemia), endocrinology (diabetes, thyroid disease, adrenal disorders), rheumatology (RA, giant cell arteritis, SLE), and hematology.

15%

Surgery, Traumatology & Surgical Emergencies

Acute abdominal conditions (appendicitis, cholecystitis, bowel obstruction, diverticulitis, incarcerated hernia), ATLS polytrauma management (cABCDE, tension pneumothorax, pelvic fractures), neurotrauma and intracranial hemorrhages, acute compartment syndrome, fracture management, vascular emergencies (ruptured AAA, acute limb ischemia, aortic dissection), and acute urological conditions (testicular torsion, obstructive pyelonephritis).

12%

Pediatrics, Neonatology & Preventive Child Health

Neonatal resuscitation (Swiss/ERC NRP guidelines), neonatal jaundice, Swiss expanded newborn metabolic screening, pediatric respiratory emergencies (croup, bronchiolitis), fever without a source in young infants, pediatric exanthems (Kawasaki disease, measles), gastrointestinal emergencies (intussusception, pyloric stenosis), minimal change nephrotic syndrome, febrile seizures, the Swiss EKIF/BAG 2+1 vaccination schedule, and Swiss child protection (Kindesschutz) law.

12%

Obstetrics, Gynecology & Women's Health

First-trimester prenatal screening (NIPT, combined test), ectopic pregnancy, hypertensive disorders of pregnancy (preeclampsia, eclampsia, magnesium sulfate), gestational diabetes mellitus (75g OGTT), antepartum hemorrhage (placenta previa, placental abruption), postpartum hemorrhage (PPH 4 Ts protocol), group B streptococcal prophylaxis, ovarian torsion, pelvic inflammatory disease, cervical cancer screening (Swiss guidelines), postmenopausal bleeding, and emergency contraception.

10%

Psychiatry, Psychotherapy & Mental Health

Major depressive episodes, bipolar affective disorder, schizophrenia and acute psychoses, anxiety and panic disorders, PTSD, substance use disorders (alcohol withdrawal CIWA-Ar and Wernicke prophylaxis, opioid use disorder and naloxone), acute delirium in elderly patients, suicide risk assessment and crisis management, refeeding syndrome in anorexia nervosa, and involuntary civil commitment (Fürsorgerische Unterbringung FU under Art. 426 ff. ZGB).

12%

Emergency Medicine, Resuscitation & Critical Care

Adult advanced life support (ERC/SRC resuscitation guidelines: shockable vs non-shockable arrest, defibrillation, adrenaline, amiodarone), STEMI and NSTEMI rapid triage and revascularization pathways, acute ischemic stroke thrombolysis and endovascular thrombectomy windows, Sepsis-3 1-hour resuscitation bundles and vasopressors, acute anaphylaxis (IM epinephrine), ARDS lung-protective ventilation, tension pneumothorax, cardiac tamponade, hypertensive emergencies, paracetamol poisoning (NAC), and massive transfusion protocols.

Primary Care, Swiss Healthcare System, Ethics & Law

Swiss mandatory health insurance framework (KVG / LAMal: basic insurance, franchises, co-payments, solidarity principle), Swiss Medical Professions Act (MedBG / LPMéd), professional medical confidentiality (Schweigepflicht Art. 321 StGB) and lawful exemptions, patient decision-making capacity (Urteilsfähigkeit Art. 16 ZGB), informed consent, advance healthcare directives (Patientenverfügung Art. 370 ZGB), legal representation, Swiss SAMW/ASSM end-of-life and assisted suicide guidelines (Art. 115 StGB), mandatory communicable disease reporting (EpG), and primary care preventive screening.

Clinical Pharmacology & Toxicology

Cytochrome P450 drug interactions (CYP3A4 inducers and inhibitors), direct oral anticoagulants (DOACs) and specific reversal agents (idarucizumab, andexanet alfa), renal drug dosing adjustments and toxicity prevention, Swiss antimicrobial stewardship guidelines (SSI) for common outpatient and hospital-acquired infections, drug-induced QT prolongation / Torsades de Pointes, and Swissmedic mandatory pharmacovigilance adverse drug reaction reporting.

How to Pass the Eidgenössisches Examen Humanmedizin Exam

What You Need to Know

Passing score: Criterion-referenced standard passing score established annually by MEBEKO for the written CK examination, and a minimum station pass threshold for the practical CS OSCE examination
Assessment: Two independent national examination components: 1) Clinical Knowledge (CK) written computer-based exam consisting of 240 single-best-answer MCQs (administered in two 195-minute sessions over two half-days), and 2) Clinical Skills (CS) practical examination consisting of 11 standardized OSCE stations (13 minutes per station with standardized patients, physical exam, procedural tasks, and communication). Both components are governed by MEBEKO and must be passed independently according to MedBG regulations (no compensation is permitted).
Time limit: 390 minutes written examination (two 195-minute sessions) plus approximately 3.5 hours for the 11 practical OSCE stations
Exam fee: CHF 200 registration fee + CHF 1,500 examination fee + CHF 500 federal diploma issuance fee (Total: CHF 2,200)

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Eidgenössisches Examen Humanmedizin Study Tips from Top Performers

1Master Emergency Decision-Making Algorithms: Be fluent in first-line emergency protocols including adult/pediatric ALS resuscitation, acute anaphylaxis management (intramuscular epinephrine in the anterolateral thigh), status epilepticus step-up therapy, septic shock bundles, and acute stroke thrombolysis/thrombectomy time windows.

2Understand PROFILES Clinical Reasoning & Diagnostic Pathways: Practice systematically working through diagnostic criteria, gold-standard imaging modalities (e.g., non-contrast CT for acute stroke, CT angiography for PE and acute mesenteric ischemia, ultrasound for acute cholecystitis and appendicitis), and lab interpretation.

3Memorize the Swiss Vaccination Schedule & Preventive Guidelines: Review the EKIF/BAG 2+1 infant vaccination schedule, Swiss newborn metabolic screening panel, ESPGHAN celiac disease criteria, and national cancer screening recommendations (e.g., colonoscopy / FIT screening from age 50).

4Learn Swiss Medical Jurisprudence & Ethical Frameworks: Understand the legal definitions of decision-making capacity (Urteilsfähigkeit Art. 16 ZGB), medical secrecy and statutory exemptions (Art. 321 StGB), involuntary civil commitment (Fürsorgerische Unterbringung FU under Art. 426 ff. ZGB), living wills (Patientenverfügung Art. 370 ZGB), and SAMW/ASSM end-of-life guidelines.

5Focus on Clinical Pharmacology & Swiss Antimicrobial Guidelines: Review key Cytochrome P450 interactions, DOAC dosing and reversal agents (idarucizumab, andexanet alfa), renal drug dose adjustments, and Swiss Society of Infectious Diseases (SSI) first-line antibiotic recommendations for pneumonia, UTIs, and sepsis.

Frequently Asked Questions

What is the Eidgenössische Prüfung in Humanmedizin?

The Eidgenössische Prüfung in Humanmedizin (Federal Examination in Human Medicine / Examen fédéral en médecine humaine) is the official national licensing examination taken at the conclusion of medical school (Master of Medicine) across Switzerland. Passing this examination is the statutory prerequisite for receiving the Swiss Federal Medical Diploma (Eidgenössisches Diplom als Ärztin/Arzt), which confers the legal right to practice medicine under supervision and commence postgraduate specialty residency (FMH Weiterbildung).

How is the Swiss Federal Licensing Examination structured in 2026?

The examination comprises two independent components: 1) The Clinical Knowledge (CK) written computer-based examination consisting of 240 multiple-choice questions administered over two sessions (3 hours 15 minutes each), and 2) The Clinical Skills (CS) practical examination consisting of 11 standardized OSCE stations (13 minutes per station) evaluating history taking, physical examination, communication, and procedural competence. Candidates must pass both components separately; compensation between the written and practical examinations is legally prohibited.

What are the official registration and examination fees in 2026?

Under the federal ordinance (Prüfungsverordnung MedBG), fees for human medicine candidates comprise an initial registration fee of CHF 200, an examination fee of CHF 1,500, and a federal diploma issuance fee of CHF 500, totaling CHF 2,200.

What is PROFILES and how does it relate to the examination?

PROFILES (Principal Objectives for Postgraduate Medical Training in Switzerland) is the binding national competency framework and learning objectives catalog established jointly by the Joint Commission of the Swiss Medical Schools (SMIFK) and the medical faculties. The examination questions and OSCE scenarios are mapped directly to PROFILES CanMEDS competencies, Entrustable Professional Activities (EPAs), and clinical situations.

In what languages is the official federal exam administered?

The official national examination is administered in the Swiss official languages German and French (with candidates choosing their preferred testing language during registration). This OpenExamPrep question bank provides an English-language multiple-choice adaptation designed to support bilingual medical education, international graduates, and structured clinical reasoning.

What happens if a candidate fails one component of the federal examination?

If a candidate passes one component (e.g., written CK) but fails the other (e.g., practical CS OSCE), only the failed component must be repeated during the subsequent annual examination cycle. Under MedBG regulations, a candidate has a maximum of three attempts per component to pass the federal medical examination.